World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000495045
Reproduction Date:

Title: Epitope  
Author: World Heritage Encyclopedia
Language: English
Subject: Linear epitope, Immunogenicity, Avidity, Antibody, Paratope
Collection: Antigenic Determinant, Immune System
Publisher: World Heritage Encyclopedia


An epitope, also known as antigenic determinant, is the part of an antigen that is recognized by the immune system, specifically by antibodies, B cells, or T cells. For example, the epitope is the specific piece of the antigen that an antibody binds to. The part of an antibody that binds to the epitope is called a paratope. Although epitopes are usually non-self proteins, sequences derived from the host that can be recognized (as in the case of autoimmune diseases) are also epitopes.

The epitopes of protein antigens are divided into two categories, conformational epitopes and linear epitopes, based on their structure and interaction with the paratope.[1] A conformational epitope is composed of discontinuous sections of the antigen's amino acid sequence. These epitopes interact with the paratope based on the 3-D surface features and shape or tertiary structure of the antigen. The proportion of epitopes that are conformational is unknown.

By contrast, linear epitopes interact with the paratope based on their primary structure. A linear epitope is formed by a continuous sequence of amino acids from the antigen.


  • Function 1
    • T cell epitopes 1.1
    • Cross-activity 1.2
  • Epitope mapping 2
  • Epitope tags 3
  • See also 4
  • References 5
  • External links 6
    • Epitope prediction methods 6.1
    • Epitope databases 6.2


T cell epitopes

T cell epitopes are presented on the surface of an antigen-presenting cell, where they are bound to MHC molecules. In humans, professional antigen-presenting cells are specialized to present MHC class II peptides, whereas most nucleated somatic cells present MHC class I peptides. T cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length, whereas MHC class II molecules present longer peptides, 13-17 amino acids in length,[2] and non-classical MHC molecules also present non-peptidic epitopes such as glycolipids.


Epitopes are sometimes cross-reactive. This property is exploited by the immune system in regulation by anti-idiotypic antibodies (originally proposed by Nobel laureate Niels Kaj Jerne). If an antibody binds to an antigen's epitope, the paratope could become the epitope for another antibody that will then bind to it. If this second antibody is of IgM class, its binding can upregulate the immune response; if the second antibody is of IgG class, its binding can downregulate the immune response.

Epitope mapping

Epitopes can be mapped using protein microarrays, and with the ELISPOT or ELISA techniques.

MHC class I and II epitopes can be reliably predicted by computational means alone,[3] although not all in-silico T cell epitope prediction algorithms are equivalent in their accuracy.[4]

Epitope tags

Epitopes are often used in proteomics and the study of other gene products. Using recombinant DNA techniques genetic sequences coding for epitopes that are recognized by common antibodies can be fused to the gene. Following synthesis, the resulting epitope tag allows the antibody to find the protein or other gene product enabling lab techniques for localisation, purification, and further molecular characterisation. Common epitopes used for this purpose are Myc-tag, HA-tag, FLAG-tag, GST-tag, 6xHis[5] and OLLAS.[6] Peptides can also be bound by proteins that form covalent bonds to the peptide, allowing irreversible immobilisation.[7]

See also


  1. ^ Huang, J.; Honda, W. (2006). "CED: a conformational epitope database". BMC Immunology 7: 7.  
  2. ^ Alberts (2002). Molecular Biology of the Cell. New York: Garland Science. p. 1401. 
  3. ^ Koren, E.; AS De Groot (July 7, 2007). "Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein". Clinical Immunology 124 (1).  
  4. ^ De Groot, Anne; W. Martin (May 2009). "Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics". Clinical Immunology 131 (2).  
  5. ^ Walker, John; Ralph Rapley (2008). Molecular biomethods handbook. Humana Press. p. 467.  
  6. ^ Novus, Biologicals. "OLLAS Epitope Tag". Novus Biologicals. Retrieved 23 November 2011. 
  7. ^ Zakeri, B. (2012). "Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin". Proceedings of the National Academy of Sciences 109 (12): E690–7.  

External links

  • Antibodies bind to conformational shapes on the surfaces of antigens (Janeway Immunobiology Section 3.8)
  • Antigens can bind in pockets or grooves, or on extended surfaces in the binding sites of antibodies (Janeway Immunobiology Figure 3.8)

Epitope prediction methods

  • LBEEP : Harnessing Computational Biology for Exact Linear B-Cell Epitope Prediction: A Novel Amino Acid Composition-Based Feature Descriptor. [1]
  • Lbtope: Improved Method for Linear B-Cell Epitope Prediction Using Antigen’s Primary Sequence. PLoS ONE 8(5): e62216
  • BCEP: Prediction of B-cell epitopes using protein 3D structures.

Epitope databases

  • MHCBN: A database of MHC/TAP binder and T-cell epitopes
  • Bcipep: A database of B-cell epitopes
  • SYFPEITHI - First online database of T cell epitopes
  • IEDB - Database of T and B cell epitopes with annotation of recognition context - NIH funded
  • ANTIJEN - T and B cell epitope database at the Jenner institute, UK
  • IMGT/3Dstructure-DB - Three-dimensional structures of B and T cell epitopes with annotation of IG and TR - IMGT, Montpellier, France
  • SEDB: A Structural Epitope Database- Pondicheery University, DIT funded
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.